Sign in
CompletedNo phase

Long Term Follow up Patients With Premature Ovarian Failure ex Vivo Gene Therapy

Key facts

Who runs it
Ukraine Association of Biobank
Where
Ukraine1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
86 people enrolled
Started
1 Sept 2020
Ended
30 Sept 2025
Type of study
Observational
Treatments tested
  • Observational
Record updated
22 December 2025

Who can take part

Age
18 years to 40 years
Sex
Women only

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Provision of written informed consent for this study by subjects or as applicable parent legal guardian. Treated with drug product for therapy of premature ovarian insufficiency in a Institute Bio-Stem Cell Rehabilitation UAB clinical study
  • Diagnosed of premature ovarian insufficiency ESHRE:
  • Women age of 18 to 40 years
  • Have experienced 4 months of oligo/amenorrhea
  • Two serum follicle-stimulating hormone (FSH was >40 mIU/ml levels in the menopausal range, obtained at least a month apart
  • lower FSH levels ( 25 mIU/ml)
  • anti-Müllerian hormone (AMH) serum levels ( 3.0 ng/ml)

Who cannot take part

  • There are no exclusion criteria for this study

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This is a multi-centers of long term safety and efficacy follow up study for patients with premature ovarian failure (the women aged younger than 40 years, who present with amenorrhoea, hypergonadotropic hypogonadism, and infertility) who have been treated with ex vivo gene therapy drug product in Institute of Bio-Stem Cell Rehabilitation UAB - sponsored clinical studies. After completing the parent clinical study (approximately 6 month), eligible subject will be followed for additional 2 years for total of 2 years and 6 month post drug product infusion. No investigation drug product will be administered in the study

Treatments tested

  • Observational

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Long Term Follow up Patients With Premature Ovarian Failure ex Vivo Gene Therapy Using Autologous Mesenchymal Stem Cell and Mesenchymal Stem Cell Lyophilisate
Record updated
22 December 2025